BlackRock, Inc. 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
BlackRock Inc. BLK |
5,294,844 11.300% |
567,858 (+12.01%) |
Filing |
| 2023-03-08 2:19 pm Purchase |
2023-02-28 | 13G | United Therapeutics Corporation UTHR |
BlackRock Inc. BLK |
4,726,986 10.200% |
216,775 (+4.81%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
BlackRock Inc. BLK |
4,510,211 9.900% |
271,036 (+6.39%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
BlackRock Inc. BLK |
4,239,175 9.400% |
-33,949 (-0.79%) |
Filing |
| 2021-02-01 08:23 am Sale |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
BlackRock Inc. BLK |
4,273,124 9.600% |
-367,961 (-7.93%) |
Filing |